Project Editors
Holly Yang, MD MSHPEd HMDC FACP FAAHPM
Toluwalase Ajayi, MD
Kyle P. Edmonds, MD

Authors and Reviewers
Toluwalase Ajayi, MD
Robert M. Arnold, MD FAAHPM
Christi Bartlett, MD
Jennifer K. Burke, DO
Julie Childers, MD
Paul L. DeSandre, DO
Kyle P. Edmonds, MD
Nathan Fairman, MD MPH
Paul Glare, MD
Michelle Grant-Ervin, MD MHPE FACEP
Yuya Hagiwara, MD
Christopher Jones, MD
Laurel Kilpatrick, MD
Sangeeta Lamba, MD
Tiffany Latta, DO
Jane E. Loitman, MD MBA MS FAAHPM
Britni Lookabaugh, MD
Monica Malec, MD
Dominic Moore, MD
Beth Popp, MD
Karin Porter-Williamson, MD FAAHPM
Emily Riegel, MD
Joseph Rotella, MD MBA FAAHPM HMDC
Joseph W. Shega, MD
Robert M. Taylor, MD FAAHPM
Jason A. Webb, MD
Holly Yang, MD MSHPEd HMDC FACP FAAHPM

Disclosures

AAHPM endorses the standards of the Accreditation Council for Continuing Medical Education (ACCME). All who are in a position to control or influence the content of an educational activity must disclose all relevant financial relationships with an ineligible companies that they have had over the past 24 months. *Disclosures documents were reviewed for potential conflicts of interest and, if identified, they were mitigated prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.

All editors, authors, reviewers and staff have disclosed no relevant financial relationships with the following exceptions: Beth Popp serves on PRA Health’s Safety Monitoring Committee for Clinical Trials and receives an honorarium. Robert Taylor serves on the speaker’s bureau of HospiScript and receives an honorarium.

*An ineligible company is defined as those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients. Eligible companies are those whose mission and function are 1. providing clinical services directly to patients; or 2. The education of healthcare professionals, or 3. Serving as fiduciary to patients, the public, or population health; and other organizations that are not otherwise ineligible. (Examples of such organizations include: ambulatory procedure centers, blood banks, diagnostic labs that do not sell proprietary products, electronic health record companies, government or military agencies, group medical practices, health law firms, health profession membership organizations, hospitals or healthcare delivery systems, infusion centers, insurance or managed care companies, nursing homes, pharmacies that do not manufacture proprietary compounds, publishing or education companies, rehabilitation centers, schools of medicine or health science universities, or software, or software or game developers.)